Silva, Camila Fonseca Amorim da 
; Camalhonte, Samanta Omae ; Almeida, Michell Oliveira ; Araujo, Sheila Cruz ; Sannomiya, Miriam ; Lago, João Henrique Ghilardi ; Honorio, Kathia Maria
Source: Drugs and Drug Candidates. Unidades: EACH, BIOTECNOLOGIA, IQSC
Assunto: COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Camila Fonseca Amorim da et al. Effect of the N501Y mutation on ligands complexed with SARS-CoV-2 RBD: insights on potential drug candidates for COVID-19. Drugs and Drug Candidates, v. 2, n. 2, p. 433-458, 2023Tradução . . Disponível em: https://doi.org/10.3390/ddc2020022. Acesso em: 03 nov. 2024.APA
Silva, C. F. A. da, Camalhonte, S. O., Almeida, M. O., Araujo, S. C., Sannomiya, M., Lago, J. H. G., & Honorio, K. M. (2023). Effect of the N501Y mutation on ligands complexed with SARS-CoV-2 RBD: insights on potential drug candidates for COVID-19. Drugs and Drug Candidates, 2( 2), 433-458. doi:10.3390/ddc2020022NLM
Silva CFA da, Camalhonte SO, Almeida MO, Araujo SC, Sannomiya M, Lago JHG, Honorio KM. Effect of the N501Y mutation on ligands complexed with SARS-CoV-2 RBD: insights on potential drug candidates for COVID-19 [Internet]. Drugs and Drug Candidates. 2023 ; 2( 2): 433-458.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/ddc2020022Vancouver
Silva CFA da, Camalhonte SO, Almeida MO, Araujo SC, Sannomiya M, Lago JHG, Honorio KM. Effect of the N501Y mutation on ligands complexed with SARS-CoV-2 RBD: insights on potential drug candidates for COVID-19 [Internet]. Drugs and Drug Candidates. 2023 ; 2( 2): 433-458.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/ddc2020022
